News

VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...
Researchers have discovered in a new study that glucocorticoid-induced adrenal insufficiency (GIAI) was rare (1.9%) in ...
VivaVision Biotech (VivaVision), a clinical-stage, privately held biotechnology company focused on developing innovative treatments for ocular diseases, today announced positive topline results from ...
Glucocorticoid-induced adrenal insufficiency was lower in prevalence than previously estimated among patients with PMR or GCA.
The following is a summary of “Changes in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone,” published in the March 2025 issue of JAMA Network Open by Hansen et al.